𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Immunogenicity and safety of a new inactivated Hepatitis A Vaccine: a clinical trial with comparison of administration route

✍ Scribed by Alain Fisch; Pascal Cadilhac; Emmanuel Vidor; Thierry Prazuck; Alain Dublanchet; Christian Lafaix

Book ID
116117130
Publisher
Elsevier Science
Year
1996
Tongue
English
Weight
637 KB
Volume
14
Category
Article
ISSN
0264-410X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Immunogenicity and safety of a new inact
Immunogenicity and safety of a new inactivated hepatitis a vaccine in a comparative study
✍ Dr. Christian Goilav; Jane Zuckerman; Michael Lafrenz; Emmanuel Vidor; Sabine La πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 668 KB

## Abstract A multicentre, controlled, randomised, open, comparative trial including 839 healthy adult volunteers was carried out in order to compare the immunogenicity and reactogenicity of two vaccines against hepatitis A virus (HAV) during primary immunization and after booster injection. The fi

Single dose inactivated hepatitis A vacc
Single dose inactivated hepatitis A vaccine: Rationale and clinical assessment of the safety and immunogenicity
✍ Dr. P. van Damme; C. MatheΓ―; S. Thoelen; A. Meheus; A. Safary; F. E. AndrΓ© πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 537 KB

## Abstract In comparison with the classical immunisation schedules (0‐1‐6 or 0‐1‐12 months) for hepatitis A, a 0‐ and 12‐ or a 0‐ and 6‐month schedule would have important advantages by reducing the number of injections and discomfort and increasing scheduling convenience and patient compliance. I